|
Contents
|
|
|
|
Gliomas
|
|
|
|
|
Gorovets
D, Kannan K, Shen R, Kastenhuber E, Islamdoust N, Campos C, Pentsova E,
Jhanwar SC, Heguy A, Mellinghoff IK, Chan TA, Huse JT.
IDH Mutation and Neuroglial
Developmental Features Define Clinically Distinct Subclasses of Lower-Grade
Diffuse Astrocytic Glioma.
Clin Cancer Res. 2012 Mar 13;.
[Epub ahead of print]
.JPG) Abstract |
.png)
Reprint |
.gif) Related articles
|
|
|
Gozé C, Bezzina C, Gozé E, Rigau V, Maudelonde T, Bauchet L, Duffau H.
1P19Q loss but not IDH1
mutations influences WHO grade II gliomas spontaneous growth.
J Neurooncol. 2012 Mar 6;. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Ichimura
K.
Molecular pathogenesis of IDH
mutations in gliomas.
Brain Tumor Pathol. 2012 Mar
8;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Juratli
TA, Kirsch M, Robel K, Soucek S, Geiger K, von Kummer R, Schackert G, Krex
D.
IDH
mutations as an early and consistent marker in low-grade astrocytomas WHO
grade II and their consecutive secondary high-grade gliomas.
J
Neurooncol. 2012 Mar 13. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Raghunathan
A, Olar A, Vogel H, Parker JR, Coventry SC, Debski R, Albarracin CT, Aldape
KD, Cahill DP 3rd, Powell SZ, Fuller GN.
Isocitrate
dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
Ann
Diagn Pathol. 2012 Mar 22;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
|
